New therapeutic targets for cancer bone metastasis
- PMID: 25962679
- PMCID: PMC4461455
- DOI: 10.1016/j.tips.2015.04.006
New therapeutic targets for cancer bone metastasis
Abstract
Bone metastases are dejected consequences of many types of tumors including breast, prostate, lung, kidney, and thyroid cancers. This complicated process begins with the successful tumor cell epithelial-mesenchymal transition, escape from the original site, and penetration into the circulation. The homing of tumor cells to the bone depends on both tumor-intrinsic traits and various molecules supplied by the bone metastatic niche. The colonization and growth of cancer cells in the osseous environment, which awaken their dormancy to form micro- and macro-metastasis, involve an intricate interaction between the circulating tumor cells and local bone cells including osteoclasts, osteoblasts, adipocytes, and macrophages. We discuss the most recent advances in the identification of new molecules and novel mechanisms during each step of bone metastasis that may serve as promising therapeutic targets.
Keywords: bone metastatic niche; bone microenvironment; macrometastasis; osteoblast; osteoclast; tumor-intrinsic factors.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Figures


Similar articles
-
Examining the metastatic niche: targeting the microenvironment.Semin Oncol. 2010 Oct;37 Suppl 2:S2-14. doi: 10.1053/j.seminoncol.2010.10.007. Semin Oncol. 2010. PMID: 21111245 Review.
-
Targeting Intercellular Communication in the Bone Microenvironment to Prevent Disseminated Tumor Cell Escape from Dormancy and Bone Metastatic Tumor Growth.Int J Mol Sci. 2021 Mar 13;22(6):2911. doi: 10.3390/ijms22062911. Int J Mol Sci. 2021. PMID: 33805598 Free PMC article. Review.
-
Crosstalk between cancer cells and bone microenvironment in bone metastasis.Biochem Biophys Res Commun. 2005 Mar 18;328(3):679-87. doi: 10.1016/j.bbrc.2004.11.070. Biochem Biophys Res Commun. 2005. PMID: 15694401 Review.
-
HIF targets in bone remodeling and metastatic disease.Pharmacol Ther. 2015 Jun;150:169-77. doi: 10.1016/j.pharmthera.2015.02.002. Epub 2015 Feb 12. Pharmacol Ther. 2015. PMID: 25681658 Free PMC article. Review.
-
The stem cell niche as a pharmaceutical target for prevention of skeletal metastases.Anticancer Agents Med Chem. 2012 Mar;12(3):187-93. doi: 10.2174/187152012800228797. Anticancer Agents Med Chem. 2012. PMID: 22044002 Review.
Cited by
-
Precise Diagnosis and Therapy of Bone Cancer Using Near-Infrared Lights.Front Bioeng Biotechnol. 2021 Nov 18;9:771153. doi: 10.3389/fbioe.2021.771153. eCollection 2021. Front Bioeng Biotechnol. 2021. PMID: 34869286 Free PMC article. Review.
-
Targeting the Metastatic Bone Microenvironment by MicroRNAs.Front Endocrinol (Lausanne). 2018 Apr 27;9:202. doi: 10.3389/fendo.2018.00202. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 29780354 Free PMC article. Review.
-
Tumour dormancy in inflammatory microenvironment: A promising therapeutic strategy for cancer-related bone metastasis.Cell Mol Life Sci. 2020 Dec;77(24):5149-5169. doi: 10.1007/s00018-020-03572-1. Epub 2020 Jun 16. Cell Mol Life Sci. 2020. PMID: 32556373 Free PMC article. Review.
-
The Role of Pre-Clinical 3-Dimensional Models of Osteosarcoma.Int J Mol Sci. 2020 Jul 31;21(15):5499. doi: 10.3390/ijms21155499. Int J Mol Sci. 2020. PMID: 32752092 Free PMC article. Review.
-
MicroRNAs and Osteolytic Bone Metastasis: The Roles of MicroRNAs in Tumor-Induced Osteoclast Differentiation.J Clin Med. 2015 Aug 28;4(9):1741-52. doi: 10.3390/jcm4091741. J Clin Med. 2015. PMID: 26343739 Free PMC article. Review.
References
-
- Randall RL. A promise to our patients with metastatic bone disease. Ann Surg Oncol. 2014;21:4049–4050. - PubMed
-
- Davila D, et al. Evaluation of Osseous Metastasis in Bone Scintigraphy. Seminars in Nuclear Medicine. 2015;45:3–15. - PubMed
-
- Quinn RH, et al. Contemporary management of metastatic bone disease: tips and tools of the trade for general practitioners. Instr Course Lect. 2014;63:431–441. - PubMed
-
- Taubenberger AV. In vitro microenvironments to study breast cancer bone colonisation. Adv. Drug Deliv. Rev. 2014;79-80C:135–144. - PubMed
-
- Jandial R. Metastatic Cancer. Clinical and Biological Perspective. 2013:1–314.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical